A growth equity firm that invests in companies that are commercializing high-margin life sciences products.
Business Model: B2B
Revenue: $5.5M
Employees: 11-50
Address: 452 5th Ave
City: New York
State: NY
Zip: 10018
Country: US
HighCape partners (“HighCape”) is a growth equity firm that invests in companies that are commercializing high-margin life sciences products. They transform Their portfolio companies into scalable commercial entities (SCEs), allowing them to become sustainable businesses with multiple exit alternatives.
Contact Phone:
+12125218495
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2020 | Alphina Therapeutics | Venture Round | - |
6/2017 | Zipline Medical | Series E | 12M |
9/2019 | Wellinks | Series B | 0 |
11/2021 | Wellinks | Series C | 0 |
6/2017 | Aziyo Biologics | Venture Round | 12M |
3/2021 | Cybrexa Therapeutics | Series B | 25M |
6/2017 | Cybrexa Therapeutics | Series B | 6M |
6/2018 | Zipline Medical | Growth | 9M |
7/2022 | Modifi Bio | Seed Round | 6.4M |
9/2019 | Flyp Nebulizer | Series B | 0 |
6/2014 | Cheetah Medical | Series C | 5M |
6/2019 | Cybrexa Therapeutics | Series B | 13.4M |
9/2017 | Cheetah Medical | Series C | 0 |
7/2022 | Modifi Bio | Seed Round | 0 |
11/2021 | Wellinks | Series C | 0 |
3/2021 | Cybrexa Therapeutics | Series B | 0 |
12/2020 | Alphina Therapeutics | Venture Round | - |
9/2019 | Flyp Nebulizer | Series B | 0 |
9/2019 | Wellinks | Series B | 0 |
6/2019 | Cybrexa Therapeutics | Series B | 0 |
6/2018 | Zipline Medical | Series F | 0 |
9/2017 | Cheetah Medical | Series C | 0 |
6/2017 | Cybrexa Therapeutics | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|